Papers
1
Total Citations
3
H-Index
1
About
Rui-jie Lin is a rising surgical researcher whose work focuses on the comparative effectiveness of robotic surgical platforms, particularly in colorectal oncology. Lin’s most-cited paper, a systematic review and meta-analysis published in 2025, rigorously compares perioperative outcomes and oncological efficacy between the Da Vinci Si and Da Vinci Xi robotic systems in colorectal surgery. This study synthesizes data from controlled trials to evaluate key metrics such as operative time, blood loss, conversion rates, and long-term cancer control, providing crucial evidence for surgical decision-making. While still early in their career, with the paper already garnering 3 citations, Lin’s work addresses a pressing clinical question: whether technological upgrades in robotic surgery translate into meaningful patient benefits. By systematically analyzing the nuances of these platforms, Lin contributes to the optimization of minimally invasive techniques, helping surgeons select the most appropriate technology for complex colorectal procedures. Their research is particularly valuable for institutions considering costly robotic system upgrades, offering an evidence-based perspective on whether the Xi system’s enhanced features—such as improved range of motion and patient clearance—yield superior outcomes. Lin’s dedication to rigorous meta-analytic methods and clinically relevant questions marks them as a thoughtful contributor to the field of surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1